FUJIFILM Corporation | Medical Imaging & Endoscopy Solutions

FUJIFILM Corporation | Medical Imaging & Endoscopy Solutions

4

Company Profile

FUJIFILM Corporation is a Japan-based manufacturer of    medical imaging and endoscopy systems, headquartered at    7-3, Akasaka 9-chome, Minato-ku, Tokyo 107-0052, Japan. Originally founded as    Fuji Photo Film Co., Ltd. in 1934, the company transformed into a holding company structure in    2006 and now operates as the core healthcare and imaging subsidiary of    FUJIFILM Holdings Corporation (TYO: 4901), led by President and CEO    Teiichi Goto. The company employs approximately 72,600 staff across    270 consolidated subsidiaries, serving hospitals, clinics and healthcare systems in over    100 countries. The Americas healthcare division,    FUJIFILM Healthcare Americas Corporation, is headquartered in    Lexington, Massachusetts, United States.

Core Products & Technologies

Medical Imaging Systems

Diagnostic X-ray: Digital radiography (DR) and computed radiography (CR) systems for general radiology and fluoroscopy
   • Computed Tomography (CT): Advanced CT scanners for diagnostic and interventional applications
   • Magnetic Resonance Imaging (MRI): High-field MRI systems for neurological, musculoskeletal and body imaging
   • Ultrasound: ARIETTA series diagnostic ultrasound systems including the ARIETTA 850 premium processor for radiology, women's health and point-of-care applications
   • Enterprise Imaging / PACS: SYNAPSE medical IT platform for image storage, workflow management and AI-assisted diagnostics

Endoscopy & Endosurgical Solutions

ELUXEO 8000 Endoscopic Imaging System: A next-generation 4K LED multi-light processor and light source with proprietary Amber-Red Color Imaging (ACI), Triple Noise Reduction (3NR) and extended dynamic range, launched in 2025
   • 800 Series Endoscopes: Advanced CMOS-equipped gastroscopes, colonoscopes and therapeutic scopes including the EG-840T, EG-840TP ultra-slim therapeutic gastroscope and EG-860R
   • Endoscopic Ultrasound (EUS): ARIETTA 850 EUS processor and EG-740UT curved linear EUS scope for fine-needle aspiration and therapeutic stent placement
   • Double Balloon Enteroscopy: EN-840T DBE scope enabling full small-intestine access for diagnosis and therapeutic intervention
   • Endosurgical Devices: ESD/EMR knives, hemostasis clips, biliary and pulmonary therapeutic tools
   • TRACMOTION: An innovative grasping device for ESD procedures enabling easy re-grasping of large lesions, demonstrated at DDW 2026

Software & AI Solutions

SYNAPSE Enterprise Imaging: A vendor-neutral archive and workflow platform integrating radiology, cardiology, pathology and enterprise imaging data
   • AI-Powered Diagnostic Tools: CAD Eye AI for polyp detection in colonoscopy; AI-assisted image analysis for radiology and endoscopy workflows
   • Shear Wave Elastography & iATT: Advanced quantitative ultrasound tools for liver assessment and endohepatology applications on the ARIETTA 850 platform

Regenerative Medicine

SAVYSCUS® Injection: An autologous synovial mesenchymal stem cell regenerative medical product for meniscal injuries, approved by Japan's Ministry of Health, Labour and Welfare in May 2026 under the Pharmaceutical and Medical Device Act

Market Position & Certifications

FUJIFILM holds a top-tier position in the global medical imaging and endoscopy markets,    competing with Olympus in endoscopy,    GE HealthCare and    Philips Healthcare in ultrasound and diagnostic imaging, and    Canon Medical Systems and    Siemens Healthineers across modalities. Key strengths include:

90+ years of Japanese engineering heritage in imaging science and materials technology
   • Endoscopy leadership: Global number-two position in GI endoscopy behind Olympus, with double-digit market share and strength in GI suites and therapeutic portfolios
   • Ultrasound market: Approximately 13% global market share, ranking third worldwide with particular traction in point-of-care and women's health segments
   • Regulatory compliance: FDA-cleared; CE marked for European and select global markets; compliant with international medical device standards
   • AI innovation: CAD Eye and integrated AI workflows recognized for advancing diagnostic accuracy and clinical efficiency
   • Industry recognition: Named 2026 TIME100 Influential Company and Industry Leader; ELUXEO 8000 + EG-840TP won 2026 MedTech Breakthrough Award for Best New Endoscopy Technology Solution; 23 products received 2026 iF Design Award

Corporate Timeline

1934 — Founded as Fuji Photo Film Co., Ltd. in Japan
   2006 — Transforms into a holding company structure, establishing FUJIFILM Holdings Corporation and FUJIFILM Corporation as the operating entity
   2018 — Launches ELUXEO endoscopic imaging system with LED multi-light technology in the United States
   2021 — Announces VISION2023 healthcare growth strategy targeting expanded global market share
   2025 — Introduces ELUXEO 8000 next-generation endoscopic imaging system and launches interventional ultrasonic endoscope in Europe
   2026 — ELUXEO 8000 and EG-840TP gastroscope win MedTech Breakthrough Award; named TIME100 Influential Company; ARIETTA 850 software update adds Shear Wave Elastography and iATT for endohepatology; 23 products receive iF Design Award; SAVYSCUS® Injection approved in Japan for meniscal injuries

Target Markets & Applications

Gastroenterology & Endoscopy: ELUXEO 8000 and 800 series scopes for upper GI, colonoscopy, third space endoscopy (TSE) and ESD procedures in hospital and ambulatory settings
   • Diagnostic Radiology: X-ray, CT, MRI and ultrasound systems for general radiology, emergency medicine and specialty imaging departments
   • Endoscopic Ultrasound: ARIETTA 850 and 700 series EUS platforms for pancreaticobiliary diagnosis, fine-needle aspiration and therapeutic stenting
   • Enterprise Imaging: SYNAPSE PACS and VNA solutions for large health system workflow integration and AI-assisted diagnostic pathways
   • Point-of-Care Ultrasound: ARIETTA portable systems for bedside diagnostics, women's health and perioperative imaging
   • Regenerative Medicine: SAVYSCUS® stem cell therapy for orthopedic applications in the Japanese market

Contact Information

Global Headquarters

Address: 7-3, Akasaka 9-chome, Minato-ku, Tokyo 107-0052, Japan

Americas Healthcare Headquarters

Address: Lexington, Massachusetts, United States

Parent Company

FUJIFILM Holdings Corporation
   Address: 7-3, Akasaka 9-chome, Minato-ku, Tokyo 107-0052, Japan
   Stock: TYO: 4901
   Website: fujifilm.com
   Investor Relations: holdings.fujifilm.com/en/investors/

文章下方广告位

网友评论

访客信息

你已经3分钟没有访问该网站

这些可能是你需要的内容: